首页> 外文会议>Biophotonics and immune responses VI >Topical photosan-mediated photodynamic therapy for DMBA-induced hamster buccal pouch early cancer lesions - an in vivo study
【24h】

Topical photosan-mediated photodynamic therapy for DMBA-induced hamster buccal pouch early cancer lesions - an in vivo study

机译:DMBA诱导的仓鼠颊囊局部早期癌病灶的局部光子介导的光动力疗法-体内研究

获取原文
获取原文并翻译 | 示例

摘要

Oral cancer has becomes the most prominent cancer disease in recent years in Taiwan. The reason is the betel nut chewing habit combing with smoking and alcohol-drinking lifestyle of people results in oral cancer becomes the fastest growth incident cancer amongst other major cancer diseases. In previous studies showed that photosan, haematoporphyrin derivative (HPD), has demonstrated effective PDT results on human head and neck disease studies. To avoid the systemic phototoxic effect of photosan, this study was designed to use a topical photosan-mediated PDT for treatment of DMBA-induced hamster buccal pouch cancerous lesions. DMBA was applied to one of the buccal pouches of hamsters thrice a week for 10 to 12 weeks. Cancerous lesions were induced and proven by histological examination. These DMBA-induced cancerous lesions were used for testing the efficacy of topical photosan-mediated PDT. Before PDT, fluorescence spectroscopy was used to determine when photosan reached its peak level in the lesional epithelial cells after topical application of photosan gel. We found that photosan reached its peak level in cancerous lesions about 13.5 min after topical application of photosan gel. The cancerous lesions in hamsters were then treated with topical photosan-mediated PDT (fluence rate: 600 mW/cm2; light exposure dose 200 J/cm2) using the portable Lumacare 635 nm fiber-guided light device. Visual examination demonstrated that topical photosan-mediated PDT was an applicable treatment modality for DMBA-induced hamster buccal pouch cancerous lesions.
机译:近年来,口腔癌已成为台湾最突出的癌症。原因是槟榔咀嚼习惯与人们吸烟和酗酒的生活方式相结合,导致口腔癌成为其他主要癌症疾病中增长最快的事件。先前的研究表明,血红素卟啉衍生物(HPD)光合作用已在人的头颈疾病研究中证明了有效的PDT结果。为了避免光烷的全身光毒性作用,本研究旨在使用局部光烷介导的PDT治疗DMBA诱导的仓鼠颊囊癌性病变。将DMBA每周三次三次应用于仓鼠的颊袋之一,持续10至12周。癌性病变被诱导并通过组织学检查证实。这些DMBA诱导的癌性病变用于测试局部光子介导的PDT的功效。在PDT之前,使用荧光光谱法确定局部应用光敏胶后,光敏剂在病变上皮细胞中何时达到其峰值水平。我们发现在局部应用光敏胶后约13.5分钟,光敏在癌性病变中达到其峰值水平。然后使用便携式Lumacare 635 nm光纤导光设备,用局部光子介导的PDT(通量率:600 mW / cm2;光照剂量200 J / cm2)治疗仓鼠中的癌性病变。视觉检查表明,局部光子介导的PDT是DMBA诱导的仓鼠颊囊癌性病变的适用治疗方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号